Precigen (PGEN) EBITDA Margin Growth (5y) (2017 - 2026)
Precigen (PGEN) EBITDA Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,639.00 |
| Dec 31, 2025 | -9,354.00 |
| Sep 30, 2025 | -356,285.00 |
| Jun 30, 2025 | -402,821.00 |
| Mar 31, 2025 | -162,938.00 |
| Dec 31, 2024 | -36,858.00 |
| Sep 30, 2024 | -212.60 Mn |
| Jun 30, 2024 | -841,999.00 |
| Mar 31, 2024 | -210,670.00 |
| Dec 31, 2023 | -213,607.00 |
| Sep 30, 2023 | -209.35 Mn |
| Jun 30, 2023 | -111,387.00 |
| Dec 31, 2022 | 18,425.00 |
| Sep 30, 2022 | 4,518.00 |
| Jun 30, 2022 | -76,523.00 |
| Mar 31, 2022 | -34,318.00 |
| Dec 31, 2021 | 28,789.00 |
| Sep 30, 2021 | -58,713.00 |
| Jun 30, 2021 | -64,295.00 |
| Mar 31, 2021 | 2,115.00 |